Gene · 10112
Papers1,613
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,613
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Aberrant pace of cortical neuron development in brain organoids from patients with 22q11.2 deletion syndrome-associated schizophrenia. | Nat Commun | 2025 | 40750773 | PubTator, text mining | PubMed |
| Progress of targeted FOX family therapy in ovarian cancer. | Front Pharmacol | 2025 | 40746724 | PubTator, text mining | PubMed |
| Nitidine chloride may mediate its antitumor effects by targeting kinesin family member 20A in colorectal cancer cells. | World J Clin Oncol | 2025 | 40741189 | PubTator, text mining | PubMed |
| Kinesin-related genes stratified the prognosis and immune responses of clear cell renal cell carcinoma. | Eur J Med Res | 2025 | 40660314 | PubTator, text mining | PubMed |
| DEPDC1 facilitated malignant phenotypes and disease progression of liposarcoma by modulating KIF20A. | Front Endocrinol (Lausanne) | 2025 | 40600015 | PubTator, text mining | PubMed |
| Inhibiting kinesin family member 20A disrupts Zika virus entry by blocking internalization. | J Microbiol | 2025 | 40598997 | PubTator, text mining | PubMed |
| MCM4 as Potential Metastatic Biomarker in Lung Adenocarcinoma. | Diagnostics (Basel) | 2025 | 40564876 | PubTator, text mining | PubMed |
| Nanoplastics Enhance Transmembrane Transport and Uptake of Carcinogens: Transcriptional Changes and the Effects of Weathering. | Adv Sci (Weinh) | 2025 | 40538222 | PubTator, text mining | PubMed |
| A novel ferroptosis-related signature for predicting prognosis, immune characteristics, and treatment prediction in hepatocellular carcinoma. | PLoS One | 2025 | 40465746 | PubTator, text mining | PubMed |
| Exploratory Analysis of Molecular Subtypes in Early-Stage Osteosarcoma: Identifying Resistance and Optimizing Therapy. | Cancers (Basel) | 2025 | 40427174 | PubTator, text mining | PubMed |
| Bioinformatics and system biology approach to discover the common pathogenetic processes between COVID-19 and chronic hepatitis B. | PLoS One | 2025 | 40408617 | PubTator, text mining | PubMed |
| KIF20A promotes triple-negative breast cancer progression via activation of the IL-17 signaling pathway. | Biochem Biophys Res Commun | 2025 | 40393105 | PubTator, text mining | PubMed |
Identification of key biomarker genes in liver hepatocellular carcinoma and kidney renal clear cell carcinoma progression: A shared high-throughput screening and molecular docking method with potentials for targeted therapeutic interventions. | J Genet Eng Biotechnol | 2025 | 40390492 | PubTator, text mining | PubMed |
| Decoding the role of microtubules: a trafficking road for vesicle. | Theranostics | 2025 | 40303338 | PubTator, text mining | PubMed |
| Unraveling the Therapeutic Potential of Scutellarin for Clear Cell Renal Cell Carcinoma: A Comprehensive Molecular Analysis. | Curr Pharm Des | 2025 | 40265430 | PubTator, text mining | PubMed |
| Transcriptomic signatures of prostate cancer progression: a comprehensive RNA-seq study. | 3 Biotech | 2025 | 40260408 | PubTator, text mining | PubMed |
| The glycolytic characteristics of hepatocellular carcinoma and its interaction with the microenvironment: a comprehensive omics study. | J Transl Med | 2025 | 40211257 | PubTator, text mining | PubMed |
| Identification of ferroptosis-related gene signatures as a novel prognostic model for clear cell renal cell carcinoma. | Discov Oncol | 2025 | 40178680 | PubTator, text mining | PubMed |
| Metabolic-associated fatty liver disease (MAFLD) promotes the progression of hepatocellular carcinoma by enhancing KIF20A expression. | Int Immunopharmacol | 2025 | 40168801 | PubTator, text mining | PubMed |
| Discovering potential therapeutic targets in glioblastoma multiforme using a multi-omics approach. | Pathol Res Pract | 2025 | 40168776 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10112/papers?page=5